25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ST Pharm Co.Ltd
Buy, Hold or Sell?

Let's analyze ST Pharm Co.Ltd together

I guess you are interested in ST Pharm Co.Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of ST Pharm Co.Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ST Pharm Co.Ltd

I send you an email if I find something interesting about ST Pharm Co.Ltd.

1. Quick Overview

1.1. Quick analysis of ST Pharm Co.Ltd (30 sec.)










1.2. What can you expect buying and holding a share of ST Pharm Co.Ltd? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
56.7%

What is your share worth?

Current worth
₩22,617.76
Expected worth in 1 year
₩27,129.58
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
₩4,511.82
Return On Investment
5.4%

For what price can you sell your share?

Current Price per Share
₩83,600.00
Expected price per share
₩70,621 - ₩101,500
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of ST Pharm Co.Ltd (5 min.)




Live pricePrice per Share (EOD)
₩83,600.00

2.2. Growth of ST Pharm Co.Ltd (5 min.)




Is ST Pharm Co.Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$299.7m$235.8m$41.6m15.0%

How much money is ST Pharm Co.Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.7m$3.1m$681.7k17.9%
Net Profit Margin7.5%7.3%--

How much money comes from the company's main activities?

2.3. Financial Health of ST Pharm Co.Ltd (5 min.)




2.4. Comparing to competitors in the Pharmaceuticals industry (5 min.)




  Industry Rankings (Pharmaceuticals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of ST Pharm Co.Ltd?

Welcome investor! ST Pharm Co.Ltd's management wants to use your money to grow the business. In return you get a share of ST Pharm Co.Ltd.

First you should know what it really means to hold a share of ST Pharm Co.Ltd. And how you can make/lose money.

Speculation

The Price per Share of ST Pharm Co.Ltd is ₩83,600. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ST Pharm Co.Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ST Pharm Co.Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩22,617.76. Based on the TTM, the Book Value Change Per Share is ₩1,127.96 per quarter. Based on the YOY, the Book Value Change Per Share is ₩269.31 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ST Pharm Co.Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.040.0%0.200.0%0.170.0%0.050.0%0.070.0%
Usd Book Value Change Per Share1.360.0%0.790.0%0.190.0%0.200.0%0.530.0%
Usd Dividend Per Share0.000.0%0.000.0%0.260.0%0.140.0%0.200.0%
Usd Total Gains Per Share1.360.0%0.790.0%0.450.0%0.340.0%0.730.0%
Usd Price Per Share59.85-55.74-56.18-54.33-43.65-
Price to Earnings Ratio400.44-147.38-141.65-60.69-49.74-
Price-to-Total Gains Ratio43.97-276.82--233.65-142.97-149.88-
Price to Book Ratio3.78-3.79-4.48-4.45-3.56-
Price-to-Total Gains Ratio43.97-276.82--233.65-142.97-149.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share58.52
Number of shares17
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.14
Usd Book Value Change Per Share0.790.20
Usd Total Gains Per Share0.790.34
Gains per Quarter (17 shares)13.425.82
Gains per Year (17 shares)53.6923.29
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
105444101413
2010798192836
30161152294159
40215206385582
502682604869105
603223145783128
703763686796151
8043042276110174
9048347686124197
10053753095138220

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%13.07.00.065.0%19.011.00.063.3%19.011.00.063.3%
Book Value Change Per Share4.00.00.0100.0%10.02.00.083.3%13.07.00.065.0%18.012.00.060.0%18.012.00.060.0%
Dividend per Share0.00.04.00.0%6.00.06.050.0%8.00.012.040.0%17.00.013.056.7%17.00.013.056.7%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%24.06.00.080.0%24.06.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ST Pharm Co.Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1944.6371127.955+72%269.312+622%289.244+572%753.925+158%
Book Value Per Share--22617.76421002.321+8%17913.425+26%17546.069+29%17640.955+28%
Current Ratio--4.2513.584+19%1.784+138%5.443-22%6.892-38%
Debt To Asset Ratio--0.3570.405-12%0.398-10%0.316+13%0.237+51%
Debt To Equity Ratio--0.5570.688-19%0.665-16%0.504+11%0.366+52%
Dividend Per Share----0%375.000-100%200.000-100%282.623-100%
Eps--53.378287.871-81%236.726-77%66.996-20%93.931-43%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap1559641600000.000-4%1618848792000.0001503101205550.000+8%1509404406375.000+7%1456450512485.000+11%1169709055823.333+38%
Net Profit Margin--0.0230.075-70%0.073-69%-0.004+116%-0.014+161%
Operating Margin----0%0.019-100%-0.0490%-0.0670%
Operating Ratio--1.3151.461-10%1.123+17%1.102+19%1.358-3%
Pb Ratio3.696-2%3.7803.7910%4.481-16%4.455-15%3.563+6%
Pe Ratio391.544-2%400.443147.385+172%141.655+183%60.693+560%49.741+705%
Price Per Share83600.000-2%85500.00079625.000+7%80250.000+7%77615.000+10%62358.333+37%
Price To Free Cash Flow Ratio----7.7660%-11.4890%-31.0870%-23.8480%
Price To Total Gains Ratio42.990-2%43.967276.823-84%-233.645+631%142.967-69%149.881-71%
Quick Ratio---1.039-100%0.897-100%4.496-100%4.380-100%
Return On Assets--0.0020.008-81%0.008-81%0.001+78%0.003-46%
Return On Equity--0.0020.014-83%0.013-82%0.003-22%0.005-50%
Total Gains Per Share--1944.6371127.955+72%644.312+202%489.244+297%1036.548+88%
Usd Book Value--299769799.700277467515.393+8%235850733.979+27%230431990.273+30%231513307.725+29%
Usd Book Value Change Per Share--1.3610.790+72%0.189+622%0.202+572%0.528+158%
Usd Book Value Per Share--15.83214.702+8%12.539+26%12.282+29%12.349+28%
Usd Dividend Per Share----0%0.262-100%0.140-100%0.198-100%
Usd Eps--0.0370.202-81%0.166-77%0.047-20%0.066-43%
Usd Free Cash Flow----2189434.5730%-6516279.4900%-7819920.4860%-3291175.0520%
Usd Market Cap1091749120.000-4%1133194154.4001052170843.885+8%1056583084.463+7%1019515358.740+11%818796339.076+38%
Usd Price Per Share58.520-2%59.85055.738+7%56.175+7%54.331+10%43.651+37%
Usd Profit--707463.4003798531.177-81%3116762.938-77%888037.786-20%1241130.067-43%
Usd Revenue--31214411.90047755277.204-35%47186563.606-34%34293665.781-9%30664035.277+2%
Usd Total Gains Per Share--1.3610.790+72%0.451+202%0.342+297%0.726+88%
 EOD+3 -4MRQTTM+15 -11YOY+15 -145Y+13 -1510Y+13 -15

3.3 Fundamental Score

Let's check the fundamental score of ST Pharm Co.Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15391.544
Price to Book Ratio (EOD)Between0-13.696
Net Profit Margin (MRQ)Greater than00.023
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than14.251
Debt to Asset Ratio (MRQ)Less than10.357
Debt to Equity Ratio (MRQ)Less than10.557
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.002
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of ST Pharm Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.352
Ma 20Greater thanMa 5091,970.000
Ma 50Greater thanMa 10099,226.000
Ma 100Greater thanMa 20097,360.000
OpenGreater thanClose86,800.000
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About ST Pharm Co.Ltd

ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; analytical characterization; and CMC documentation. It also provides oligonucleotide based products, such as antisense, siRNA, miRNA, aptamer, CpG, decoy, and other products; and monomer/phosphoramidite. In addition, the company offers generic APIs for anti-cancer, anti-coagulant, anti-fungal, anti-hyperlipidemia, anti-hypertensive, anti-tuberculosis, asthma, COPD, cough suppressant, diabetes mellitus, epilepsy, hepatitis B, and erectile dysfunction medicines, as well as MRI contrast agents. Further, it provides 2nd battery, electronic materials, and polymer catalysts. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is based in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 14:02:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit ST Pharm Co.Ltd earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 2.3% means that ₩0.02 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ST Pharm Co.Ltd:

  • The MRQ is 2.3%. The company is making a profit. +1
  • The TTM is 7.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM7.5%-5.3%
TTM7.5%YOY7.3%+0.3%
TTM7.5%5Y-0.4%+7.9%
5Y-0.4%10Y-1.4%+1.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%9.8%-7.5%
TTM7.5%9.5%-2.0%
YOY7.3%9.9%-2.6%
5Y-0.4%12.9%-13.3%
10Y-1.4%12.6%-14.0%
4.3.1.2. Return on Assets

Shows how efficient ST Pharm Co.Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • 0.2% Return on Assets means that ST Pharm Co.Ltd generated ₩0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ST Pharm Co.Ltd:

  • The MRQ is 0.2%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.8%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM0.8%-0.7%
TTM0.8%YOY0.8%+0.0%
TTM0.8%5Y0.1%+0.7%
5Y0.1%10Y0.3%-0.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%3.6%-3.4%
TTM0.8%3.5%-2.7%
YOY0.8%5.3%-4.5%
5Y0.1%5.9%-5.8%
10Y0.3%4.9%-4.6%
4.3.1.3. Return on Equity

Shows how efficient ST Pharm Co.Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • 0.2% Return on Equity means ST Pharm Co.Ltd generated ₩0.00 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ST Pharm Co.Ltd:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.2%TTM1.4%-1.2%
TTM1.4%YOY1.3%+0.1%
TTM1.4%5Y0.3%+1.1%
5Y0.3%10Y0.5%-0.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2%4.6%-4.4%
TTM1.4%4.6%-3.2%
YOY1.3%8.2%-6.9%
5Y0.3%9.1%-8.8%
10Y0.5%10.3%-9.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ST Pharm Co.Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient ST Pharm Co.Ltd is operating .

  • Measures how much profit ST Pharm Co.Ltd makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ST Pharm Co.Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1.9%-1.9%
TTM-5Y-4.9%+4.9%
5Y-4.9%10Y-6.7%+1.8%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.2%-13.2%
TTM-12.0%-12.0%
YOY1.9%12.4%-10.5%
5Y-4.9%8.6%-13.5%
10Y-6.7%12.1%-18.8%
4.3.2.2. Operating Ratio

Measures how efficient ST Pharm Co.Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.31 means that the operating costs are ₩1.31 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 1.315. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.461. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.315TTM1.461-0.146
TTM1.461YOY1.123+0.338
TTM1.4615Y1.102+0.358
5Y1.10210Y1.358-0.255
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3151.225+0.090
TTM1.4611.220+0.241
YOY1.1231.311-0.188
5Y1.1021.249-0.147
10Y1.3581.240+0.118
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ST Pharm Co.Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if ST Pharm Co.Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 4.25 means the company has ₩4.25 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 4.251. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.584. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.251TTM3.584+0.667
TTM3.584YOY1.784+1.800
TTM3.5845Y5.443-1.859
5Y5.44310Y6.892-1.449
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2512.213+2.038
TTM3.5842.234+1.350
YOY1.7842.028-0.244
5Y5.4432.199+3.244
10Y6.8921.995+4.897
4.4.3.2. Quick Ratio

Measures if ST Pharm Co.Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.039-1.039
TTM1.039YOY0.897+0.142
TTM1.0395Y4.496-3.458
5Y4.49610Y4.380+0.116
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.926-0.926
TTM1.0390.973+0.066
YOY0.8971.515-0.618
5Y4.4961.591+2.905
10Y4.3801.399+2.981
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ST Pharm Co.Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of ST Pharm Co.Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ST Pharm Co.Ltd to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.36 means that ST Pharm Co.Ltd assets are financed with 35.7% credit (debt) and the remaining percentage (100% - 35.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 0.357. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.405. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.357TTM0.405-0.048
TTM0.405YOY0.398+0.007
TTM0.4055Y0.316+0.089
5Y0.31610Y0.237+0.079
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3570.345+0.012
TTM0.4050.339+0.066
YOY0.3980.333+0.065
5Y0.3160.315+0.001
10Y0.2370.339-0.102
4.5.4.2. Debt to Equity Ratio

Measures if ST Pharm Co.Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 55.7% means that company has ₩0.56 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 0.557. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.688. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.557TTM0.688-0.131
TTM0.688YOY0.665+0.024
TTM0.6885Y0.504+0.185
5Y0.50410Y0.366+0.138
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5570.547+0.010
TTM0.6880.547+0.141
YOY0.6650.499+0.166
5Y0.5040.476+0.028
10Y0.3660.548-0.182
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings ST Pharm Co.Ltd generates.

  • Above 15 is considered overpriced but always compare ST Pharm Co.Ltd to the Pharmaceuticals industry mean.
  • A PE ratio of 400.44 means the investor is paying ₩400.44 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ST Pharm Co.Ltd:

  • The EOD is 391.544. Based on the earnings, the company is expensive. -2
  • The MRQ is 400.443. Based on the earnings, the company is expensive. -2
  • The TTM is 147.385. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD391.544MRQ400.443-8.899
MRQ400.443TTM147.385+253.058
TTM147.385YOY141.655+5.730
TTM147.3855Y60.693+86.692
5Y60.69310Y49.741+10.952
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD391.54427.863+363.681
MRQ400.44329.844+370.599
TTM147.38527.532+119.853
YOY141.65523.102+118.553
5Y60.69327.577+33.116
10Y49.74129.248+20.493
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ST Pharm Co.Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-7.766+7.766
TTM-7.766YOY-11.489+3.723
TTM-7.7665Y-31.087+23.321
5Y-31.08710Y-23.848-7.239
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.531-29.531
TTM-7.76629.447-37.213
YOY-11.48926.360-37.849
5Y-31.08731.734-62.821
10Y-23.84834.357-58.205
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of ST Pharm Co.Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.78 means the investor is paying ₩3.78 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of ST Pharm Co.Ltd:

  • The EOD is 3.696. Based on the equity, the company is fair priced.
  • The MRQ is 3.780. Based on the equity, the company is fair priced.
  • The TTM is 3.791. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.696MRQ3.780-0.084
MRQ3.780TTM3.791-0.011
TTM3.791YOY4.481-0.690
TTM3.7915Y4.455-0.664
5Y4.45510Y3.563+0.892
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD3.6964.659-0.963
MRQ3.7803.381+0.399
TTM3.7913.209+0.582
YOY4.4812.597+1.884
5Y4.4553.278+1.177
10Y3.5634.179-0.616
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets666,216,287
Total Liabilities237,973,716
Total Stockholder Equity426,928,672
 As reported
Total Liabilities 237,973,716
Total Stockholder Equity+ 426,928,672
Total Assets = 666,216,287

Assets

Total Assets666,216,287
Total Current Assets324,411,453
Long-term Assets341,804,834
Total Current Assets
Total Current Assets  (as reported)324,411,453
Total Current Assets  (calculated)0
+/- 324,411,453
Long-term Assets
Long-term Assets  (as reported)341,804,834
Long-term Assets  (calculated)0
+/- 341,804,834

Liabilities & Shareholders' Equity

Total Current Liabilities76,312,565
Long-term Liabilities161,661,151
Total Stockholder Equity426,928,672
Total Current Liabilities
Total Current Liabilities  (as reported)76,312,565
Total Current Liabilities  (calculated)0
+/- 76,312,565
Long-term Liabilities
Long-term Liabilities  (as reported)161,661,151
Long-term Liabilities  (calculated)0
+/- 161,661,151
Total Stockholder Equity
Total Stockholder Equity (as reported)426,928,672
Total Stockholder Equity (calculated)0
+/- 426,928,672
Other
Common Stock Shares Outstanding 18,934
Net Invested Capital 426,928,672
Net Working Capital 248,098,888



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
388,796,126
373,807,204
378,934,826
381,504,269
376,359,818
366,164,680
353,612,831
345,505,352
341,273,837
329,669,851
330,548,517
341,080,335
340,382,340
341,640,574
338,649,909
445,570,131
445,957,005
469,748,350
487,306,305
498,565,214
507,235,706
528,729,728
538,766,279
570,652,265
574,549,264
555,739,792
648,614,973
675,436,089
675,822,396
666,216,287
666,216,287675,822,396675,436,089648,614,973555,739,792574,549,264570,652,265538,766,279528,729,728507,235,706498,565,214487,306,305469,748,350445,957,005445,570,131338,649,909341,640,574340,382,340341,080,335330,548,517329,669,851341,273,837345,505,352353,612,831366,164,680376,359,818381,504,269378,934,826373,807,204388,796,126
   > Total Current Assets 
0
227,944,084
229,408,680
225,205,294
213,129,643
196,363,401
178,890,760
167,298,559
161,452,359
149,461,440
149,330,457
144,152,390
139,852,479
132,757,564
128,507,343
235,613,276
229,625,346
239,937,606
246,369,188
244,141,732
236,591,289
250,070,336
250,789,110
263,233,822
257,693,420
232,179,964
320,354,359
348,378,135
341,417,183
324,411,453
324,411,453341,417,183348,378,135320,354,359232,179,964257,693,420263,233,822250,789,110250,070,336236,591,289244,141,732246,369,188239,937,606229,625,346235,613,276128,507,343132,757,564139,852,479144,152,390149,330,457149,461,440161,452,359167,298,559178,890,760196,363,401213,129,643225,205,294229,408,680227,944,0840
       Cash And Cash Equivalents 
0
74,831,738
80,199,960
72,301,316
80,212,086
69,802,276
56,910,896
47,708,812
37,094,474
15,604,052
12,058,304
74,664
13,736,178
23,685,694
28,125,548
8,704,000
17,769,926
27,280,769
42,006,694
27,348,238
0
0
0
50,201,066
44,614,629
34,357,773
21,488,486
50,097,156
71,125,461
0
071,125,46150,097,15621,488,48634,357,77344,614,62950,201,06600027,348,23842,006,69427,280,76917,769,9268,704,00028,125,54823,685,69413,736,17874,66412,058,30415,604,05237,094,47447,708,81256,910,89669,802,27680,212,08672,301,31680,199,96074,831,7380
       Short-term Investments 
0
60,000,000
60,000,000
60,000,000
60,000,000
60,000,000
60,000,000
60,000,000
60,000,000
61,762,397
62,736,787
38,169,800
0
0
16,035,978
102,011,338
113,910,751
96,395,315
70,681,940
54,013,000
60,241,093
57,522,130
52,314,105
0
30,288,371
9,569,730
82,105,408
40,000,000
45,595,059
0
045,595,05940,000,00082,105,4089,569,73030,288,371052,314,10557,522,13060,241,09354,013,00070,681,94096,395,315113,910,751102,011,33816,035,9780038,169,80062,736,78761,762,39760,000,00060,000,00060,000,00060,000,00060,000,00060,000,00060,000,00060,000,0000
       Net Receivables 
13,796,405
10,997,016
10,424,917
31,435,539
16,657,960
19,354,407
13,084,134
16,505,956
18,436,040
16,187,697
17,691,071
35,698,490
19,729,589
28,879,210
20,022,453
46,671,282
33,888,304
38,687,338
45,291,194
64,448,100
37,718,588
46,058,561
56,049,221
94,349,812
46,676,532
46,251,234
57,561,927
120,566,257
72,760,436
0
072,760,436120,566,25757,561,92746,251,23446,676,53294,349,81256,049,22146,058,56137,718,58864,448,10045,291,19438,687,33833,888,30446,671,28220,022,45328,879,21019,729,58935,698,49017,691,07116,187,69718,436,04016,505,95613,084,13419,354,40716,657,96031,435,53910,424,91710,997,01613,796,405
       Other Current Assets 
945,401
4,235,780
4,278,870
3,493,824
1,707,645
813,223
1,706,939
2,357,045
1,476,222
1,088,895
333,610
2,372,449
1,888,759
1,929,891
22,439,500
1,106,551
35,259,530
0
0
628,763
41,539,370
48,056,559
59,211,133
0
0
0
0
1
0
0
001000059,211,13348,056,55941,539,370628,7630035,259,5301,106,55122,439,5001,929,8911,888,7592,372,449333,6101,088,8951,476,2222,357,0451,706,939813,2231,707,6453,493,8244,278,8704,235,780945,401
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
307,418,443
316,855,844
323,559,828
328,260,614
327,057,954
334,405,214
341,804,834
341,804,834334,405,214327,057,954328,260,614323,559,828316,855,844307,418,44300000000000000000000000
       Property Plant Equipment 
138,728,978
141,018,090
144,653,059
151,580,023
159,234,114
165,703,164
169,063,403
169,069,310
168,418,113
166,870,907
166,210,688
172,548,074
171,921,420
171,944,969
171,153,708
175,633,730
179,741,301
191,825,914
202,154,791
210,189,716
224,948,987
234,049,797
243,250,405
257,884,967
269,913,749
276,385,864
278,211,658
280,105,453
287,076,672
0
0287,076,672280,105,453278,211,658276,385,864269,913,749257,884,967243,250,405234,049,797224,948,987210,189,716202,154,791191,825,914179,741,301175,633,730171,153,708171,944,969171,921,420172,548,074166,210,688166,870,907168,418,113169,069,310169,063,403165,703,164159,234,114151,580,023144,653,059141,018,090138,728,978
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
6,692,940
7,131,235
0
0
8,043,709
0
0
0
8,455,171
0
0
0
8,946,527
0
0
0
9,949,767
0
0
009,949,7670008,946,5270008,455,1710008,043,709007,131,2356,692,94000000000000
       Long Term Investments 
0
551,566
681,140
471,416
466,613
501,063
967,744
1,058,927
1,553,376
2,510,034
0
3,006,458
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000003,006,45802,510,0341,553,3761,058,927967,744501,063466,613471,416681,140551,5660
       Intangible Assets 
1,134,013
1,126,864
1,109,954
1,210,738
1,229,105
1,233,736
1,347,269
1,407,131
1,464,601
1,248,386
1,319,462
1,310,355
1,336,851
8,535,484
9,091,234
1,951,742
9,537,076
10,058,430
10,293,346
4,163,678
12,296,411
12,468,936
13,199,417
3,532,460
12,709,210
13,234,508
13,150,521
3,512,834
13,178,329
0
013,178,3293,512,83413,150,52113,234,50812,709,2103,532,46013,199,41712,468,93612,296,4114,163,67810,293,34610,058,4309,537,0761,951,7429,091,2348,535,4841,336,8511,310,3551,319,4621,248,3861,464,6011,407,1311,347,2691,233,7361,229,1051,210,7381,109,9541,126,8641,134,013
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
-2
0
0
00-2-100000000000000000000000000
> Total Liabilities 
71,747,285
39,576,145
36,728,514
30,421,484
33,755,005
18,608,940
12,736,285
13,936,379
24,255,478
15,635,527
16,938,566
40,122,371
42,828,135
41,189,493
45,056,036
150,242,036
155,961,052
173,558,484
182,655,610
175,591,086
192,306,492
208,440,739
205,730,245
233,020,434
238,049,274
215,189,168
269,658,310
288,529,670
284,399,390
237,973,716
237,973,716284,399,390288,529,670269,658,310215,189,168238,049,274233,020,434205,730,245208,440,739192,306,492175,591,086182,655,610173,558,484155,961,052150,242,03645,056,03641,189,49342,828,13540,122,37116,938,56615,635,52724,255,47813,936,37912,736,28518,608,94033,755,00530,421,48436,728,51439,576,14571,747,285
   > Total Current Liabilities 
68,059,287
34,895,892
31,608,131
28,637,976
31,798,409
16,160,971
9,816,068
9,954,316
19,698,373
10,544,038
10,945,409
16,227,316
18,120,700
16,488,065
20,205,587
18,610,435
23,185,509
39,375,069
45,899,462
75,365,356
88,346,171
89,713,288
85,271,433
179,223,989
189,583,003
169,706,504
155,040,776
83,744,630
88,485,073
76,312,565
76,312,56588,485,07383,744,630155,040,776169,706,504189,583,003179,223,98985,271,43389,713,28888,346,17175,365,35645,899,46239,375,06923,185,50918,610,43520,205,58716,488,06518,120,70016,227,31610,945,40910,544,03819,698,3739,954,3169,816,06816,160,97131,798,40928,637,97631,608,13134,895,89268,059,287
       Short-term Debt 
0
156,000
0
19,500
19,500
19,500
0
19,500
19,500
19,500
19,500
19,500
0
0
311,391
0
0
0
0
0
0
0
0
20,000,000
0
0
0
0
0
0
00000020,000,00000000000311,3910019,50019,50019,50019,50019,500019,50019,50019,5000156,0000
       Short Long Term Debt 
0
156,000
0
19,500
19,500
19,500
0
19,500
19,500
19,500
19,500
19,500
0
0
0
0
0
0
0
0
0
0
0
114,147,717
124,879,038
126,540,651
117,857,408
29,211,242
28,893,491
0
028,893,49129,211,242117,857,408126,540,651124,879,038114,147,7170000000000019,50019,50019,50019,50019,500019,50019,50019,5000156,0000
       Accounts payable 
6,982,588
4,522,759
0
3,110,511
2,433,314
3,719,733
0
3,086,270
4,856,401
5,465,165
5,464,668
7,164,483
10,311,074
7,104,828
0
4,694,066
0
0
0
12,865,131
0
0
0
18,095,003
11,438,056
12,154,425
11,966,728
17,660,535
13,292,083
0
013,292,08317,660,53511,966,72812,154,42511,438,05618,095,00300012,865,1310004,694,06607,104,82810,311,0747,164,4835,464,6685,465,1654,856,4013,086,27003,719,7332,433,3143,110,51104,522,7596,982,588
       Other Current Liabilities 
61,057,199
30,353,633
31,608,131
25,507,965
29,345,595
9,395,294
8,191,521
4,345,344
13,046,002
3,850,172
4,153,295
6,404,061
5,245,350
7,175,572
19,304,836
9,924,857
20,976,215
0
0
40,355,141
43,222,288
52,265,605
64,751,969
0
22,423,324
12,582,330
6,034,359
-1
9,653,572
0
09,653,572-16,034,35912,582,33022,423,324064,751,96952,265,60543,222,28840,355,1410020,976,2159,924,85719,304,8367,175,5725,245,3506,404,0614,153,2953,850,17213,046,0024,345,3448,191,5219,395,29429,345,59525,507,96531,608,13130,353,63361,057,199
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,325,286
48,466,271
45,482,664
114,617,534
204,785,040
195,914,317
161,661,151
161,661,151195,914,317204,785,040114,617,53445,482,66448,466,27150,325,28600000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
128,321
15,550,778
15,469,006
15,617,177
15,384,723
126,032,928
126,363,665
126,689,589
127,078,048
91,930,129
95,347,757
108,133,120
108,619,137
19,187,686
0
0
0
0
0
0
00000019,187,686108,619,137108,133,12095,347,75791,930,129127,078,048126,689,589126,363,665126,032,92815,384,72315,617,17715,469,00615,550,778128,3210000000000
       Capital Lease Obligations Min Short Term Debt
0
-156,000
0
-19,500
-19,500
-19,500
0
-19,500
-19,500
-19,500
-19,500
-19,500
0
0
-311,391
0
0
0
0
0
0
0
0
-16,333,565
4,018,854
3,868,065
3,543,065
3,181,490
3,582,871
0
03,582,8713,181,4903,543,0653,868,0654,018,854-16,333,56500000000-311,39100-19,500-19,500-19,500-19,500-19,5000-19,500-19,500-19,5000-156,0000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,626,511
22,668,679
24,356,588
0
22,773,420
0
022,773,420024,356,58822,668,67923,626,511000000000000000000000000
> Total Stockholder Equity
317,048,842
334,231,059
342,206,311
351,082,785
342,604,813
347,555,739
340,876,546
331,568,973
317,018,358
314,034,324
313,609,951
300,957,964
297,554,205
300,451,081
293,593,873
295,328,095
289,995,953
296,189,866
304,650,694
322,974,128
314,929,213
320,288,989
333,036,034
337,631,831
333,883,413
337,577,300
376,460,148
384,550,359
390,042,121
426,928,672
426,928,672390,042,121384,550,359376,460,148337,577,300333,883,413337,631,831333,036,034320,288,989314,929,213322,974,128304,650,694296,189,866289,995,953295,328,095293,593,873300,451,081297,554,205300,957,964313,609,951314,034,324317,018,358331,568,973340,876,546347,555,739342,604,813351,082,785342,206,311334,231,059317,048,842
   Common Stock
9,242,200
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,328,000
9,404,388
9,404,388
9,404,388
9,404,388
9,404,388
0
0
0
0
0
0
0000009,404,3889,404,3889,404,3889,404,3889,404,3889,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,328,0009,242,200
   Retained Earnings Total Equity000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
171,286,938
168,860,324
168,860,324
171,286,938
171,286,938
174,919,146
171,286,938
171,286,938
171,286,938
195,714,388
186,905,629
186,905,629
186,905,629
195,747,216
0
0
0
0
0
0
000000195,747,216186,905,629186,905,629186,905,629195,714,388171,286,938171,286,938171,286,938174,919,146171,286,938171,286,938168,860,324168,860,324171,286,9380000000000
   Treasury Stock000000000000000000000000000000
   Other Stockholders Equity 
0
-453,368
-345,276
-122,993
-133,608
-693,154
-772,287
-689,818
-702,395
-693,456
-609,256
-791,697
-591
-178,844
-73,821
-552,719
-819,184
3,912,243
4,762,964
2,265,695
1,760,735
3,729,097
6,291,803
1,246,471
0
0
0
0
0
0
0000001,246,4716,291,8033,729,0971,760,7352,265,6954,762,9643,912,243-819,184-552,719-73,821-178,844-591-791,697-609,256-693,456-702,395-689,818-772,287-693,154-133,608-122,993-345,276-453,3680



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue284,991,652
Cost of Revenue-172,876,494
Gross Profit112,115,158112,115,158
 
Operating Income (+$)
Gross Profit112,115,158
Operating Expense-251,479,991
Operating Income33,511,661-139,364,833
 
Operating Expense (+$)
Research Development30,449,585
Selling General Administrative9,780,734
Selling And Marketing Expenses0
Operating Expense251,479,99140,230,319
 
Net Interest Income (+$)
Interest Income2,439,716
Interest Expense-6,105,605
Other Finance Cost-52,737
Net Interest Income-3,718,626
 
Pretax Income (+$)
Operating Income33,511,661
Net Interest Income-3,718,626
Other Non-Operating Income Expenses0
Income Before Tax (EBT)23,354,25333,511,661
EBIT - interestExpense = -6,105,605
19,581,190
25,686,795
Interest Expense6,105,605
Earnings Before Interest and Taxes (EBIT)029,459,858
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax23,354,253
Tax Provision-5,830,843
Net Income From Continuing Ops17,523,41117,523,411
Net Income19,581,190
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net03,718,626
 

Technical Analysis of ST Pharm Co.Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ST Pharm Co.Ltd. The general trend of ST Pharm Co.Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ST Pharm Co.Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ST Pharm Co.Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 91,900 < 101,300 < 101,500.

The bearish price targets are: 72,100 > 72,000 > 70,621.

Tweet this
ST Pharm Co.Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ST Pharm Co.Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ST Pharm Co.Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ST Pharm Co.Ltd. The current macd is -4,545.90746262.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ST Pharm Co.Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ST Pharm Co.Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ST Pharm Co.Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
ST Pharm Co.Ltd Daily Moving Average Convergence/Divergence (MACD) ChartST Pharm Co.Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ST Pharm Co.Ltd. The current adx is 29.27.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell ST Pharm Co.Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
ST Pharm Co.Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ST Pharm Co.Ltd. The current sar is 92,983.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ST Pharm Co.Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ST Pharm Co.Ltd. The current rsi is 35.35. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
ST Pharm Co.Ltd Daily Relative Strength Index (RSI) ChartST Pharm Co.Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ST Pharm Co.Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ST Pharm Co.Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
ST Pharm Co.Ltd Daily Stochastic Oscillator ChartST Pharm Co.Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ST Pharm Co.Ltd. The current cci is -101.47804986.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
ST Pharm Co.Ltd Daily Commodity Channel Index (CCI) ChartST Pharm Co.Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ST Pharm Co.Ltd. The current cmo is -34.80566893.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
ST Pharm Co.Ltd Daily Chande Momentum Oscillator (CMO) ChartST Pharm Co.Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ST Pharm Co.Ltd. The current willr is -87.19211823.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
ST Pharm Co.Ltd Daily Williams %R ChartST Pharm Co.Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ST Pharm Co.Ltd.

ST Pharm Co.Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ST Pharm Co.Ltd. The current atr is 4,821.

ST Pharm Co.Ltd Daily Average True Range (ATR) ChartST Pharm Co.Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ST Pharm Co.Ltd. The current obv is 3,888,731.

ST Pharm Co.Ltd Daily On-Balance Volume (OBV) ChartST Pharm Co.Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ST Pharm Co.Ltd. The current mfi is 18.66.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
ST Pharm Co.Ltd Daily Money Flow Index (MFI) ChartST Pharm Co.Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ST Pharm Co.Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-07-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-19BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-09-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

ST Pharm Co.Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ST Pharm Co.Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.352
Ma 20Greater thanMa 5091,970.000
Ma 50Greater thanMa 10099,226.000
Ma 100Greater thanMa 20097,360.000
OpenGreater thanClose86,800.000
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of ST Pharm Co.Ltd with someone you think should read this too:
  • Are you bullish or bearish on ST Pharm Co.Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ST Pharm Co.Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ST Pharm Co.Ltd

I send you an email if I find something interesting about ST Pharm Co.Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ST Pharm Co.Ltd.

Receive notifications about ST Pharm Co.Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.